Cite
HARVARD Citation
Sehouli, J. et al. (n.d.). 00014 A PHASE II STUDY OF THE AGO OVARIAN CANCER STUDY GROUP (AGO-OVAR 2.6): ZD1839 IN COMBINATION WITH TAMOXIFEN IN REFRACTORY OVARIAN CANCER. International journal of gynecological cancer. p. 55. [Online].